Condition
Azacitidine clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Azacitidine clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Ropeginterferon Alfa-2b added to azacitidine in TP53-mutant MDS/AML
This study tests whether adding ropeginterferon alfa-2b to azacitidine helps people with TP53-mutant MDS/AML, by finding an effective dose and looking for tumor response.
-
Maintenance treatment for AML patients using ITIVA
This study is testing a new combination of treatments for people with Acute Myeloid Leukemia to see if it helps those who still have signs of the disease after chemotherapy and those who don’t.
Related topics
Quick answers
How many Azacitidine clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.